Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Charlotte Ouimet"'
Autor:
Charlotte Ouimet, Nora Hutchinson, Catherine Wang, Carol Matyka, Joseph C. Del Paggio, Jonathan Kimmelman
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-7 (2023)
Abstract Patients endure risk and uncertainty when they participate in clinical trials. We previously estimated that 12,217 patient-participants are required to bring a new cancer drug to market. However, many development efforts are aimed at extendi
Externí odkaz:
https://doaj.org/article/4e4333c0d0524cfaa0cdb75279358628
Publikováno v:
PLoS ONE, Vol 17, Iss 9, p e0274115 (2022)
BackgroundOnce a drug gets FDA approved, researchers often attempt to discover new applications in different indications. The clinical impact of such post-approval activities is uncertain. We aimed to compare the clinical impact of research efforts s
Externí odkaz:
https://doaj.org/article/91ef30b7a4ac4ffd84bfe14a21761a58
Autor:
Amanda MacPherson, Elias Gumnit, Charlotte Ouimet, Nora Hutchinson, Karl Kieburtz, Toni S. Pearson, Jonathan Kimmelman
Publikováno v:
Neurotherapeutics. 19:1507-1513
While the drug development literature provides numerous estimates of the financial costs to bring a new drug to market, the investment of patient-participants in the research process has not been described. Trial participants and their caregivers, li
To date, there are considerable delays in bringing academic innovations into clinical practice. In part, this is due to a lack of knowledge translation and communication between clinicians and scientists. While MD/PhD programs could bridge this gap,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f0c02b8ead4a83576d66f3d17d1e29a6
https://doi.org/10.1101/2023.04.09.23288339
https://doi.org/10.1101/2023.04.09.23288339
Autor:
Nora Hutchinson, Fareed A. Awan, Nicole E. Basta, Emma Feldhake, Charlotte Ouimet, Elisabeth Oliviero, Jonathan Kimmelman, Jacky Sheng, Oliver Schneider, Catherine Wang, Amanda MacPherson, Jesse Papenburg
Publikováno v:
Annals of Internal Medicine
The authors review the timelines, and probabilities, of recent vaccines progressing from phase 2 clinical trials to licensure within 10 years.
Visual Abstract. Probability of Success and Timelines of Vaccines for Viral Infectious Diseases The au
Visual Abstract. Probability of Success and Timelines of Vaccines for Viral Infectious Diseases The au